Drug Analysis: Multikine

  • ID: 4462163
  • Drug Pipelines
  • 17 pages
  • Datamonitor Healthcare
1 of 3
Drug Overview

Multikine is an investigational immunomodulator composed of a proprietary cocktail of naturally occurring cytokines such as interleukins, interferons, chemokines, and colony-stimulating factors. The therapy is administered prior to front-line surgery or radiotherapy. It is designed to activate anti-tumor immune responses and to increase tumor susceptibility to radiotherapy and chemotherapy.
Note: Product cover images may vary from those shown
2 of 3
Product Profiles
Multikine: Head and neck cancer

List of Figures
Figure 1: Multikine for head and neck cancer - SWOT analysis
Figure 2: Drug assessment summary of Multikine for SCCHN
Figure 3: Drug assessment summary of Multikine for SCCHN
Figure 4: Multikine sales for SCCHN across the US, Japan, and five major EU markets, by country, 2017-26

List of Tables
Table 1: Multikine drug profile
Table 2: Multikine Phase III trials in head and neck cancer
Table 3: Multikine early-phase data in head and neck cancer
Table 4: Multikine sales for SCCHN across the US, Japan, and five major EU markets, by country ($m), 2017-26
Table 5: Multikine patient numbers for SCCHN across the US, Japan, and five major EU markets, by country, 2017-26
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
Note: Product cover images may vary from those shown
Adroll
adroll